Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study

Oct-22

Cardiovascular

AUTHORS : Dr Ashley Jaksa, Scientific Research and Strategy, Aetion, Inc, Boston, Massachusetts, USA. Email:ashley.jaksa@aetion.com

JOURNAL : BMJ Journal

REFERENCE: 12:e064662

DOI : 0.1136/bmjopen-2022-064662

Read more